NCT00898404View on ClinicalTrials.gov

Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionRecurrent Childhood Acute Lymphoblastic LeukemiaT-cell Childhood Acute Lymphoblastic Leukemia
Interventions
OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91006-3776

Children's Oncology Group, Arcadia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00898404 - Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate | Biotech Hunter | Biotech Hunter